The best Patient Assistance Program (PAP) offered by SRK Pharmaceuticals.
Affordable Specialty Medicines Through Patient Assistance Programs
Access to essential and specialty medicines should not be limited by financial barriers.
SRK Pharmaceuticals is committed to improving patient access to high-quality specialty and critical medicines through its Patient Assistance Program (PAP). The program is designed to help eligible patients access important therapies at more affordable prices and support continuity of treatment.
SRK Pharmaceuticals works with healthcare providers, hospitals, pharmacies, distributors and international supply partners to facilitate access to specialty medicines for patients who may face affordability or availability challenges.
Our objective is simple:
Making Essential Specialty Medicines More Accessible and Affordable for Patients.What Is a Patient Assistance Program (PAP)?
A Patient Assistance Program is a structured initiative designed to help eligible patients obtain medicines when treatment costs or access challenges create a significant barrier.
Depending on the medicine, patient eligibility and applicable local requirements, assistance may involve:
Assistance with medicine availability.
SRK Pharmaceuticals Patient Assistance Program
Affordable Medicines. Better Access. Patient-Centered Care.
SRK Pharmaceuticals combines pharmaceutical manufacturing, global sourcing and distribution capabilities with a patient-focused approach to medicine access.
Our PAP network is designed to support patients and healthcare professionals across selected international markets.
Our Patient Assistance Focus
Specialty Medicines
Access support for medicines that may be expensive, specialized or difficult to source.
Oncology Medicines
Support for eligible patients requiring critical cancer therapies.
Rare Disease Medicines
Access support for therapies used in rare and orphan diseases.
Chronic Disease Medicines
Support for patients requiring long-term treatment.
International Medicine Sourcing
Coordination with international supply partners to identify appropriate medicine availability.
Treatment Continuity
Helping healthcare providers and patients maintain continuity of therapy where possible.
Affordable access to specialty medicines
Support for high-cost therapies
Oncology medicine access
Rare disease and orphan medicine access
Chronic disease treatment support
International medicine sourcing
Patient access coordination
Treatment continuity support
Coordination with physicians and healthcare providers
Hospital and pharmacy coordination.
Our Global Patient Assistance Network
SRK Pharmaceuticals supports patient access through an international network of healthcare providers, pharmacies, hospitals, distributors and supply partners. Its current PAP information identifies markets across Africa, Asia, the Middle East and other international regions.
Countries:
South Africa | Kenya | Uganda | Tanzania | Zambia | Botswana | Namibia | Zimbabwe | Rwanda | Ethiopia | Nigeria | Ghana | Egypt | Morocco | Algeria | United Arab Emirates | Saudi Arabia | Oman | Qatar | Kuwait | Bahrain | Jordan | Lebanon | Turkey | Singapore | Malaysia | Thailand | Indonesia | Vietnam | Philippines | India | Bangladesh | Nepal | Sri Lanka | Pakistan
Our international network enables SRK Pharmaceuticals to support healthcare providers, hospitals, pharmacies, distributors and eligible patients seeking access to specialty and critical medicines, subject to product availability and applicable local regulatory requirements.
Request Patient Assistance
If you are a patient, physician, hospital, pharmacy or healthcare organization looking for assistance with a specialty medicine, contact SRK Pharmaceuticals.
Patient Assistance Enquiries
Email: order@srkpharmaceuticals.com
General Enquiries: hello@srkpharmaceuticals.com
Website: www.srkpharmaceuticals.com
Please provide the medicine name, strength, dosage form, required quantity, country and relevant prescription/medical information where appropriate.
SRK Pharmaceuticals will review the enquiry and advise on available options, subject to product availability, patient eligibility and applicable regulatory requirements